Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Conti

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Plos One|May 8, 2020
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with SorafenibFrancesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Association of <i>NOS3</i> and <i>ANGPT2</i> Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE StudyAndrea Casadei-Gardini, Giorgia Marisi, Vincenzo Dadduzio, et al.
Targeted Oncology|October 28, 2020
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.
Targeted Oncology|October 12, 2020
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Identification and Retrieval of Untreated HCV-Infected Individuals Lost to Follow-Up in Italy: Results From the RECALL ProjectFabio Conti, Agnese Della Vittoria, Elisa Liverani, et al.
Biomedicines|March 28, 2025
Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control TrialsLorenzo Moccia, Francesca Bardi, Maria Benedetta Anesini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 11, 2017
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network studyAntonio Massimo Ippolito, Michele Milella, Vincenzo Messina, et al.
Journal of Hepatology|May 17, 2019
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysisFanpu Ji, Yee Hui Yeo, Mike Tzuhen Wei, et al.
Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|December 29, 2023
Best practices, errors, and perspectives of half a century of plant translocation in ItalyMartina D'Agostino, Luigi Cao Pinna, Marta Carboni, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Plos One|May 8, 2020
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with SorafenibFrancesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Association of <i>NOS3</i> and <i>ANGPT2</i> Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE StudyAndrea Casadei-Gardini, Giorgia Marisi, Vincenzo Dadduzio, et al.
Targeted Oncology|October 28, 2020
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.
Targeted Oncology|October 12, 2020
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular CarcinomaGiulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Identification and Retrieval of Untreated HCV-Infected Individuals Lost to Follow-Up in Italy: Results From the RECALL ProjectFabio Conti, Agnese Della Vittoria, Elisa Liverani, et al.
Biomedicines|March 28, 2025
Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control TrialsLorenzo Moccia, Francesca Bardi, Maria Benedetta Anesini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 11, 2017
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network studyAntonio Massimo Ippolito, Michele Milella, Vincenzo Messina, et al.
Journal of Hepatology|May 17, 2019
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysisFanpu Ji, Yee Hui Yeo, Mike Tzuhen Wei, et al.
Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|December 29, 2023
Best practices, errors, and perspectives of half a century of plant translocation in ItalyMartina D'Agostino, Luigi Cao Pinna, Marta Carboni, et al.
Pageof 11